Lapatinib–induced NF-kappaB activation sensitizes triple-negative breast cancer cells to proteasome inhibitors
2013 · Breast Cancer Research · 73 citations
https://doi.org/10.1186/bcr3575
M
Ming‐Hsin Yeh
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
15
Papers
453
Citations
10
h-index
10
i10-index
Ming‐Hsin Yeh is an academic researcher from Chung Shan Medical University Hospital. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Breast Lesions and Carcinomas. The author has an h-index of 10, co-authored 13 publications.
ORCID: 0000-0002-1090-165XPapers by this author
works<scp>MEK</scp> inhibitors induce Akt activation and drug resistance by suppressing negative feedback <scp>ERK</scp>‐mediated <scp>HER</scp>2 phosphorylation at Thr701
2017 · Molecular Oncology · 60 citations
https://doi.org/10.1002/1878-0261.12102
Lapatinib-Mediated Cyclooxygenase-2 Expression via Epidermal Growth Factor Receptor/HuR Interaction Enhances the Aggressiveness of Triple-Negative Breast Cancer Cells
2013 · Molecular Pharmacology · 36 citations
https://doi.org/10.1124/mol.112.082743
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat